INTRINSIC CAPACITIY MONITORING BY DIGITAL BIOMARKERS IN INTEGRATED CARE FOR OLDER PEOPLE (ICOPE)
A. Piau, Z. Steinmeyer, M. Cesari, J. Kornfeld, Z. Beattie, J. Kaye, B. Vellas, F. Nourhashemi
J Frailty Aging 2021;10(2)132-138
The WHO action plan on aging expects to change current clinical practices by promoting a more personalized model of medicine. To widely promote this initiative and achieve this goal, healthcare professionals need innovative monitoring tools. Use of conventional biomarkers (clinical, biological or imaging) provides a health status assessment at a given time once a capacity has declined. As a complement, continuous monitoring thanks to digital biomarkers makes it possible to remotely collect and analyze real life, ecologically valid, and continuous health related data. A seamless assessment of the patient’s health status potentially enables early diagnosis of IC decline (e.g. sub-clinical or transient events not detectable by episodic evaluations) and investigation of its probable causes. This narrative review aims to develop the concept of digital biomarkers and its implementation in IC monitoring.
A. Piau ; Z. Steinmeyer ; M. Cesari ; J. Kornfeld ; Z. Beattie ; J. Kaye ; B. Vellas ; F. Nourhashemi (2020): Intrinsic Capacitiy monitoring by digital biomarkers in Integrated Care for Older People (ICOPE). The Journal of Frailty and Aging (JFA). http://dx.doi.org/10.14283/jfa.2020.51